278 related articles for article (PubMed ID: 34476876)
21. hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients.
Johnson AC; Zhang J; Cliff Sullivan H; Wiebe C; Bray R; Gebel H; Larsen CP
Hum Immunol; 2022 Mar; 83(3):248-255. PubMed ID: 35101308
[TBL] [Abstract][Full Text] [Related]
22. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
[TBL] [Abstract][Full Text] [Related]
23. Human leukocyte antigen, allele, and eplet mismatches in liver transplantation; observations from a small, single center cohort.
Forner D; Liwski R; Alwayn I
Hum Immunol; 2018 Mar; 79(3):154-159. PubMed ID: 29289739
[TBL] [Abstract][Full Text] [Related]
24. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
[TBL] [Abstract][Full Text] [Related]
25. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
[TBL] [Abstract][Full Text] [Related]
26. Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software.
Tassone G; De Santis D; Vukovic I; Downing J; Martinez OP; D'Orsogna LJ
HLA; 2020 Jul; 96(1):52-63. PubMed ID: 32281731
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and impact of HLA and MICA allele mismatching on donor-specific antibodies induction in kidney transplant rejection.
Romphruk AV; Simtong P; Suntornnipat J; Sudwilai Y; Cheunta S; Chan-On C; Leelayuwat C
Nephrology (Carlton); 2021 Oct; 26(10):833-841. PubMed ID: 34197005
[TBL] [Abstract][Full Text] [Related]
28. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
Front Immunol; 2022; 13():844438. PubMed ID: 35799779
[TBL] [Abstract][Full Text] [Related]
29. A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity.
Wiebe C; Kosmoliaptsis V; Pochinco D; Taylor CJ; Nickerson P
Transplantation; 2018 Aug; 102(8):1338-1343. PubMed ID: 29443827
[TBL] [Abstract][Full Text] [Related]
30. Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival.
Butts RJ; Scheurer MA; Atz AM; Moussa O; Burnette AL; Hulsey TC; Savage AJ
Circ Heart Fail; 2014 Jul; 7(4):605-11. PubMed ID: 24833649
[TBL] [Abstract][Full Text] [Related]
31. Molecular-level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients - a retrospective study.
Osorio-Jaramillo E; Haasnoot GW; Kaider A; Schaefer AK; Haberl T; Goekler J; Angleitner P; Moayedifar R; Zuckermann A; Fischer GF; Laufer G; Claas FHJ; Aliabadi-Zuckermann AZ
Transpl Int; 2020 Sep; 33(9):1078-1088. PubMed ID: 32441827
[TBL] [Abstract][Full Text] [Related]
32. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
[TBL] [Abstract][Full Text] [Related]
33. Impact of HLA eplet mismatch load in immunological outcomes after living donor kidney transplantation.
Alves TA; Nascimento E; de Castro LB; Fabreti-Oliveira RA
Transpl Immunol; 2023 Oct; 80():101908. PubMed ID: 37536379
[TBL] [Abstract][Full Text] [Related]
34. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
[TBL] [Abstract][Full Text] [Related]
35. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
36. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
Reindl-Schwaighofer R; Heinzel A; Kainz A; van Setten J; Jelencsics K; Hu K; Loza BL; Kammer M; Heinze G; Hruba P; Koňaříková A; Viklicky O; Boehmig GA; Eskandary F; Fischer G; Claas F; Tan JC; Albert TJ; Patel J; Keating B; Oberbauer R;
Lancet; 2019 Mar; 393(10174):910-917. PubMed ID: 30773281
[TBL] [Abstract][Full Text] [Related]
37. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
[TBL] [Abstract][Full Text] [Related]
38. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
39. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
[TBL] [Abstract][Full Text] [Related]
40. HLA B eplet mismatches in the context of delayed graft function and low tacrolimus trough levels are risk factors influencing the generation of de novo donor-specific antibodies and acute rejection in the early stage after kidney transplantation.
Gao S; Gong H; Li M; Lan P; Zhang M; Kuang P; Zhang Y; Hu X; Ding C; Li Y; Ding X; Xue W; Zheng J
Transpl Immunol; 2023 Dec; 81():101955. PubMed ID: 37931666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
